BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17191042)

  • 1. C-kit Asp-816-Val mutation analysis in patients with mastocytosis.
    Verzijl A; Heide R; Oranje AP; van Schaik RH
    Dermatology; 2007; 214(1):15-20. PubMed ID: 17191042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cutaneous mastocytosis].
    Flageul B
    Rev Prat; 2006 Oct; 56(16):1745-51. PubMed ID: 17315498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-kit Mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation.
    Yanagihori H; Oyama N; Nakamura K; Kaneko F
    J Mol Diagn; 2005 May; 7(2):252-7. PubMed ID: 15858149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodular mastocytosis.
    Kasprowicz S; Chan IJ; Wall DJ; Tharp MD
    J Am Acad Dermatol; 2006 Aug; 55(2):347-9. PubMed ID: 16844528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis.
    Wasag B; Niedoszytko M; Piskorz A; Lange M; Renke J; Jassem E; Biernat W; Debiec-Rychter M; Limon J
    Exp Hematol; 2011 Aug; 39(8):859-65.e2. PubMed ID: 21689725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum tryptase and SCORMA (SCORing MAstocytosis) Index as disease severity parameters in childhood and adult cutaneous mastocytosis.
    Heide R; van Doorn K; Mulder PG; van Toorenenbergen AW; Beishuizen A; de Groot H; Tank B; Oranje AP
    Clin Exp Dermatol; 2009 Jun; 34(4):462-8. PubMed ID: 19077102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous mastocytosis in children: a clinical analysis of 71 cases.
    Kiszewski AE; Durán-Mckinster C; Orozco-Covarrubias L; Gutiérrez-Castrellón P; Ruiz-Maldonado R
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):285-90. PubMed ID: 15096137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT.
    Foster R; Byrnes E; Meldrum C; Griffith R; Ross G; Upjohn E; Braue A; Scott R; Varigos G; Ferrao P; Ashman LK
    Br J Dermatol; 2008 Nov; 159(5):1160-9. PubMed ID: 18795925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations.
    Bodemer C; Hermine O; Palmérini F; Yang Y; Grandpeix-Guyodo C; Leventhal PS; Hadj-Rabia S; Nasca L; Georgin-Lavialle S; Cohen-Akenine A; Launay JM; Barete S; Feger F; Arock M; Catteau B; Sans B; Stalder JF; Skowron F; Thomas L; Lorette G; Plantin P; Bordigoni P; Lortholary O; de Prost Y; Moussy A; Sobol H; Dubreuil P
    J Invest Dermatol; 2010 Mar; 130(3):804-15. PubMed ID: 19865100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial urticaria pigmentosa: report of a family and review of the role of KIT mutations.
    Fett NM; Teng J; Longley BJ
    Am J Dermatopathol; 2013 Feb; 35(1):113-6. PubMed ID: 22892471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric cutaneous mastocytosis: a review of 180 patients.
    Ben-Amitai D; Metzker A; Cohen HA
    Isr Med Assoc J; 2005 May; 7(5):320-2. PubMed ID: 15909466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paediatric mastocytosis: a systematic review of 1747 cases.
    Méni C; Bruneau J; Georgin-Lavialle S; Le Saché de Peufeilhoux L; Damaj G; Hadj-Rabia S; Fraitag S; Dubreuil P; Hermine O; Bodemer C
    Br J Dermatol; 2015 Mar; 172(3):642-51. PubMed ID: 25662299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous mastocytosis: demographic aspects and clinical features of 55 patients.
    Akoglu G; Erkin G; Cakir B; Boztepe G; Sahin S; Karaduman A; Atakan N; Akan T; Kolemen F
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):969-73. PubMed ID: 16922947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis.
    Longley BJ; Morganroth GS; Tyrrell L; Ding TG; Anderson DM; Williams DE; Halaban R
    N Engl J Med; 1993 May; 328(18):1302-7. PubMed ID: 7682288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.
    Bonadonna P; Perbellini O; Passalacqua G; Caruso B; Colarossi S; Dal Fior D; Castellani L; Bonetto C; Frattini F; Dama A; Martinelli G; Chilosi M; Senna G; Pizzolo G; Zanotti R
    J Allergy Clin Immunol; 2009 Mar; 123(3):680-6. PubMed ID: 19135713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel R634W c-kit mutation identified in familial mastocytosis.
    Pollard WL; Beachkofsky TM; Kobayashi TT
    Pediatr Dermatol; 2015; 32(2):267-70. PubMed ID: 25243845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of lesional skin c-KIT mutations with clinical phenotype in patients with mastocytosis.
    Chan IJ; Tharp MD
    Clin Exp Dermatol; 2018 Jun; 43(4):416-422. PubMed ID: 29350409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of KIT activating mutations in paediatric solitary mastocytoma.
    Ma D; Stence AA; Bossler AB; Hackman JR; Bellizzi AM
    Histopathology; 2014 Jan; 64(2):218-25. PubMed ID: 24128084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of gene mutations in KIT-positive thymic epithelial tumors.
    Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
    Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.